Cases in the Management of Polycythemia Vera: Switching From Hydroxyurea to Ruxolitinib to Resolve Symptoms and Improve Quality of Life

Srdan Verstovsek

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
JournalClinical Advances in Hematology and Oncology
Volume20
Issue number6
StatePublished - Jun 2022

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this